Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Karyopharm Therapeut (NQ: KPTI )

9.200 USD -0.030 (-0.33%)
Streaming Delayed Price Updated: 11:24 AM EDT, Apr 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 704,916
Open 9.120
Bid (Size) 9.180 (9)
Ask (Size) 9.200 (9)
Prev. Close 9.230
Today's Range 8.960 - 9.270
52wk Range 9.220 - 25.98
Shares Outstanding 74,634,291
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Karyopharm Announces Publication of Health-Related Quality of Life Outcomes from Phase 3 SEAL Study of Selinexor in Advanced Unresectable Dedifferentiated Liposarcoma in Future Oncology
- Treatment with Selinexor Demonstrated Several Potential Clinical Advantages Compared to Placebo, Including Reduction in Pain, Longer Time to Marked Clinical Deterioration of Pain and Longer Median... 
From PR Newswire
Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in... 
From PR Newswire

Performance

YTD
-45.63%
-45.63%
1 Month
-22.03%
-22.03%
3 Month
-38.99%
-38.99%
6 Month
-39.79%
-39.79%
1 Year
-63.27%
-63.27%

More News

Read More
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
Karyopharm Receives Conditional Marketing Authorization from the European Commission for NEXPOVIO® (selinexor) in Combination with Dexamethasone for the Treatment of Adult Patients with Relapsed and o
From PR Newswire
Karyopharm Stock Is Trading Higher After China's NMPA Signs Off Early-Stage ATG-019 Study In Cancer Settings
Tags General Phase 1 Trial Biotech
From Benzinga
Expanded Partnership with Medidata Supports Karyopharm’s Mission to Develop First-in-Class Therapeutics
From Business Wire News Releases
Karyopharm's Selinexor Receives Conditional Approval In Europe For Type Of Blood Cancer
Tags European Commission Biotech blood cancer
From Benzinga
Stocks That Hit 52-Week Lows On Monday
Tags Markets Intraday Update AFIB
From Benzinga
Interesting KPTI Put And Call Options For November 19th
Tags Stocks
From Market News Video
Stocks That Hit 52-Week Lows On Tuesday
Tags KPTI OSUR VGAC
From Benzinga
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
Tags VECT KPTI NRBO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.